Moderna wins $176M BARDA award to finance bird flu work

Moderna received a significant boost from the federal government, snagging a $176 million contract to help advance a bird flu vaccine.

The award, which was granted by the Biomedical Advanced Research and Development Authority (BARDA), aims to support “late-stage development” of a pre-pandemic candidate targeting the H5 avian flu strain, Moderna said Tuesday. The highly infectious subtype has infected cattle across the country with select spillover cases in humans.

Moderna said the agreement also “includes additional options to prepare and accelerate a response to future public health threats.”

Stéphane Bancel

“We are pleased to continue our collaboration with BARDA to expedite our development efforts for mRNA-based pandemic influenza vaccines and support the global public health community in preparedness against potential outbreaks,” CEO Stéphane Bancel said in a statement.

One such program, MRNA-1018, is advancing a handful of vaccine candidates through a Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks